Overview
The morbidly obese bariatric surgery population is susceptible to opioid-induced complications such as respiratory depression and postoperative nausea and vomiting. This population may in particular benefit from opioid-sparing or opioid-free anesthetic techniques. This study aims to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing bariatric surgery.
Eligibility
Inclusion Criteria:
- ASA I-III
- Non-pregnant
- Undergoing laparoscopic bariatric surgery for weight loss.
Exclusion Criteria:
- Unable to obtain informed consent or consent withdrawn.
- Patients who are pregnant or nursing.
- ASA IV-V
- Alcohol or narcotic misuse or dependence in the last 2 years.
- Preoperative daily opioid use for one year for pain management.
- Egg or soy product allergy
- Active liver disease
- Patients with left ventricular assist devices
- Abnormal renal function
- Any contraindication to any opioid or non-opioid pain analgesics
- Any physical, mental or medical condition that in the opinion of the investigator, makes study participation inadvisable.